[144] Ducommun Incorporated SEC Filing

Rhea-AI Filing Summary

Ducommun Incorporated (DCO) submitted a Form 144 proposing the sale of 3,500 common shares through Charles Schwab with an aggregate market value of $317,275.00. The filing reports 14,923,743 shares outstanding and lists the approximate date of sale as 08/12/2025 on the NYSE. The filer states the 3,500 shares were acquired in an open-market purchase on 03/24/2020 and paid for in cash. The filing also discloses two recent sales by the Stephen Oswald & Regina Oswald Foundation totaling 517 shares in May and June 2025 for combined gross proceeds of $35,845.89. The filer represents they know of no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for 3,500 DCO shares; disclosure aligns with required insider/affiliate selling procedures.

The Form 144 documents a proposed sale of 3,500 common shares valued at $317,275 through Charles Schwab with an approximate sale date of 08/12/2025. The filing records an open-market acquisition date of 03/24/2020 and cash payment. Recent related transactions show two small sales totaling 517 shares in May and June 2025. From a market-moving perspective, the quantities reported are small relative to total outstanding shares reported in the filing. The disclosure fulfils Rule 144 notice requirements and provides transparency on recent disposition activity.

Corporate Governance Expert

TL;DR: Disclosure appears complete for the proposed sale; the filer affirms no undisclosed material adverse information.

The filing includes acquisition, payment, broker, and recent sale details and contains the seller's representation that they are not aware of undisclosed material adverse information. The inclusion of prior sales by the Stephen Oswald & Regina Oswald Foundation adds context on recent dispositions. As a governance matter, the form documents compliance with Rule 144 notice expectations but does not by itself indicate strategic corporate changes or governance issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp 3000 Schwab Way Westlake TX 76262	3500	317275.00	14923743	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/24/2020	Open Market Purchase	Open Market			3500	03/24/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stephen Oswald & Regina Oswald Foundation 600 Anton Boulevard, Suite 1100, Costa Mesa CA 92626	Common	06/04/2025	267	19234.68
Stephen Oswald & Regina Oswald Foundation 600 Anton Boulevard Suite 1100, Costa Mesa CA 92626	Common	05/14/2025	250	16611.21

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the Ducommun (DCO) Form 144 propose to sell?

The filing proposes to sell 3,500 common shares of Ducommun Incorporated.

What is the aggregate market value and broker for the proposed DCO sale?

The aggregate market value is listed as $317,275.00 and the broker is Charles Schwab Corp.

When were the shares acquired that are proposed for sale in the Form 144?

The 3,500 shares were acquired in an open-market purchase on 03/24/2020 and paid for in cash.

When is the approximate date of sale listed in the filing?

The filing lists the approximate date of sale as 08/12/2025 on the NYSE.

Were any DCO securities sold by the filer in the past three months?

Yes. The filing discloses two sales by the Stephen Oswald & Regina Oswald Foundation: 267 shares on 06/04/2025 for $19,234.68 and 250 shares on 05/14/2025 for $16,611.21.

Does the filer claim any undisclosed material adverse information about Ducommun?

The filer represents by signing the notice that they do not know of any material adverse information about the issuer that has not been publicly disclosed.